Skyrizi Subcutaneous Injection 180mg Autodoser, containing risankizumab (genetical recombination), is a biologic medication manufactured by AbbVie. It is used for conditions like moderate to severe plaque psoriasis and active psoriatic arthritis, and is provided as a 180mg 1.2mL kit with YJ code 3999450G5023.
Skyrizi Subcutaneous Injection 180mg Autodoser
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).